The Psychedelic Report

By: Dr. Dave Rabin
Listen for free

  • Summary

  • Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr. Dave brings you the latest news and answers your questions to share perspectives from the front lines of this exciting movement.
    Copyright Future Medicine Media
    Show more Show less
Episodes
  • Ketamine and the Matthew Perry Tragedy

    Ketamine and the Matthew Perry Tragedy
    Sep 30 2024
    In this episode, Dr. Dave Rabin and Dr. Jonathan Edwards tackle the controversial topic of ketamine in light of the tragic death of actor Matthew Perry. Together, they explore the safety profile of ketamine, its legitimate uses in treating depression and suicidal ideation, and dispel misinformation regarding its association with Perry's passing.Dr. Edwards, a leading expert in ketamine-assisted therapy and author of The Revolutionary Ketamine, offers his insights on the pressing need for effective mental health treatments. As suicide rates continue to rise, particularly among young people, this episode emphasizes the potential of ketamine as a life-saving treatment and the importance of therapy in conjunction with medication.Tune in to gain a deeper understanding of ketamine’s role in mental health and how it can potentially save lives.
    • The Revolutionary Ketamine on Amazon
    • Stopping Pain: A Revolutionary Approach on Amazon
    • Dr. Jonathan Edwards' Website
    • Subscribe to Dr. Edwards' Substack
    • Web: https://psychedelic.support/
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    Show more Show less
    32 mins
  • Making the Good Vibes Last with Shawn Wells

    Making the Good Vibes Last with Shawn Wells
    Sep 11 2024
    How do we optimize our bodies and our brains for learning new things? In this episode of The Psychedelic Report, Dr. Dave Rabin welcomes back nutritional biochemist Shawn Wells to explore the often-overlooked topic of post-psychedelic supplementation. They discuss how to optimize the benefits of psychedelic experiences and ensure that the transformations achieved during these journeys can last longer.
    Shawn shares his expertise on various supplements, nutrients, and dietary strategies that can enhance neuroplasticity, support mental health, and promote overall well-being after a psychedelic experience. The conversation covers essential topics such as hydration, the role of adaptogens, the importance of neurotransmitter repletion, and the impact of diet on recovery.
    Tune in for valuable insights from leading experts in the field of Psychedelic Medicine.

    Optimizing Psychedelic Medicine Experiences with Shawn Wells

    • Web: https://shawnwells.com/
    • Instagram: https://www.instagram.com/shawnwells
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    • Web: www.ApolloNeuro.com
    Show more Show less
    56 mins
  • The FDA Rejects MDMA-Assisted Therapy

    The FDA Rejects MDMA-Assisted Therapy
    Aug 28 2024
    In this episode, Dr. Dave Rabin discusses the impact of the FDA's decision, the potential delays in accessing this crucial treatment, and the unethical behavior of certain organizations influencing the FDA. Dr. Rabin is joined by Jon Lubecky, a retired army sergeant and Veteran who took part in MAPS MDMA therapy trials, as he discusses the implications of this rejection and emphasizes the need for ongoing advocacy and hope for eventual approval. The episode also addresses the unethical behavior of Symposia, an organization accused of falsifying information to the FDA to obstruct MDMA therapy approval. Additionally, former Symposia member David Nichols reveals serious ethical violations within the organization, raising questions about their motives and funding. Through these discussions, the episode highlights the critical need for transparency, ethical practices, and continued efforts to ensure access to psychedelic treatments for those in need.
    Rachel Nuwer’s Scientific American Article: https://www.scientificamerican.com/article/fdas-rejection-of-mdma-psychotherapy-for-trauma-draws-criticism-from/
    Jon Lubecky’s Conversation with David Nickles on Breaking Points: https://www.youtube.com/watch?v=lttFB0c0cAo
    • Web: https://psychedelic.support/
    • Twitter: https://twitter.com/DrDavidRabin
    • Instagram: https://www.instagram.com/drdavidrabin
    • Web: https://www.drdave.io/
    Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193
    Show more Show less
    41 mins
Alternative & Complementary Medicine Physical Illness & Disease Psychology Hygiene & Healthy Living
Show more Show less

What listeners say about The Psychedelic Report

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available